
Laura Hammitt
Professor · Johns Hopkins Bloomberg School of Public Health
Credentials: · · ·
History
- 2008–2011
Pediatric Infectious Diseases

- 2001–2005
Doctor of Medicine
Research
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
New England Journal of Medicine · 2020 · 11,647 citations
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
New England Journal of Medicine · 2021 · 1,180 citations
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
New England Journal of Medicine · 2022 · First of 19 authors · 868 citations
- KO
59 papers

29 papers

28 papers

24 papers

16 papers

13 papers
- RS
13 papers

11 papers
Grants
- 2024–2026
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $452.4K · Johns Hopkins University
- 2021–2026
National Institute of General Medical Sciences · S06
Project lead · $930K · White Mountain Apache Tribe
- 2019–2024
NCIRD · U01
Contact PI · $10.3M · Johns Hopkins University
- 2021–2024
Project Safe Schools: Re-Opening Schools SAFELY for Native American Youth
National Institute of Child Health and Human Development · OT2
PI · $4.8M · Johns Hopkins University
Clinical trials
- 2024–2025
Staph Intervention for Effective Local Defense
Principal investigator · Completed · Phase 4
Johns Hopkins Bloomberg School of Public Health
- 2022–2023
Principal investigator · Completed · Phase 4
Johns Hopkins Bloomberg School of Public Health
- 2021
Protecting Native Families From COVID-19
Principal investigator · Completed
Johns Hopkins Bloomberg School of Public Health
- 2005–2006
VaxTeen Hepatitis B Vaccine Booster Study
Principal investigator · Completed · Phase 4
Centers for Disease Control and Prevention

